GCG and Stroke: A potential explanation for the fact that pharmacologically administered GLP-1 analogues show acute neuroprotective efficacy in the rodent while endogenous GLP-1 levels do not correlate with stroke recovery in patients could be that treatment with pharmacological agents in rodents are often given in higher doses.